GoHealth, Inc.
GOCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.50 | 0.03 | 0.02 | -0.00 |
| FCF Yield | -26.44% | 76.97% | 53.70% | -79.36% |
| EV / EBITDA | 3.57 | 23.90 | -2.97 | -2.58 |
| Quality | ||||
| ROIC | -0.85% | -6.76% | -22.68% | -26.27% |
| Gross Margin | 83.65% | 78.36% | 70.29% | 77.47% |
| Cash Conversion Ratio | 2.95 | -0.72 | -0.16 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.14% | -11.57% | -10.37% | 25.34% |
| Free Cash Flow Growth | -137.04% | 101.32% | 114.87% | -147.64% |
| Safety | ||||
| Net Debt / EBITDA | 2.80 | 18.76 | -2.56 | -1.56 |
| Interest Coverage | -0.10 | -1.18 | -5.58 | -14.61 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -168.38 | -146.12 | -70.03 | -121.38 |